COX15 | Cytochrome c oxidase assembly homolog 15 (yeast) | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CRHR1 | Corticotropin releasing hormone receptor 1 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CRHR2 | Corticotropin releasing hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CXCR4 | Chemokine (C-X-C motif) receptor 4 | Cancer-related genes CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CYBB | Cytochrome b-245, beta polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYSLTR1 | Cysteinyl leukotriene receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCST1 | DC-STAMP domain containing 1 | Predicted membrane proteins
| | | | | Tissue enriched |
DCST2 | DC-STAMP domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DRD3 | Dopamine receptor D3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
DRD4 | Dopamine receptor D4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
DUOX1 | Dual oxidase 1 | Enzymes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ELOVL1 | ELOVL fatty acid elongase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ELOVL3 | ELOVL fatty acid elongase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ELOVL4 | ELOVL fatty acid elongase 4 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ELOVL5 | ELOVL fatty acid elongase 5 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ELOVL6 | ELOVL fatty acid elongase 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F2R | Coagulation factor II (thrombin) receptor | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
F2RL1 | Coagulation factor II (thrombin) receptor-like 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
F2RL3 | Coagulation factor II (thrombin) receptor-like 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
FFAR1 | Free fatty acid receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FLVCR1 | Feline leukemia virus subgroup C cellular receptor 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
FLVCR2 | Feline leukemia virus subgroup C cellular receptor family, member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FPR3 | Formyl peptide receptor 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
FZD10 | Frizzled class receptor 10 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |